| P50 | author | Megumi Ota | Q59691620 |
| P2093 | author name string | Yasuko Mori | |
| | Kouki Murakami | |
| | Masaaki Matsuura | |
| | Koichi Yamanishi | |
| | Yasuyuki Gomi | |
| P2860 | cites work | Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector | Q24563904 |
| | Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 |
| | A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | Q28254168 |
| | The safety profile of varicella vaccine: a 10-year review | Q28276798 |
| | Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor | Q28474768 |
| | Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 |
| | Respiratory syncytial virus infection in elderly adults. | Q30351086 |
| | Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va | Q33707803 |
| | Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations | Q33900029 |
| | Respiratory syncytial virus and parainfluenza virus | Q33952428 |
| | Live vaccine used to prevent the spread of varicella in children in hospital | Q34202755 |
| | Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector | Q34302198 |
| | Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. | Q34590637 |
| | Varicella-zoster virus as a live vector for the expression of foreign genes | Q34629086 |
| | Sendai virus-based RSV vaccine protects African green monkeys from RSV infection | Q35667184 |
| | Effectiveness of live varicella vaccine | Q35681513 |
| | Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome | Q36155097 |
| | Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro | Q36465730 |
| | Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic | Q36823131 |
| | Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity | Q36919232 |
| | Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity | Q37401975 |
| | Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys | Q37568127 |
| | Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains. | Q39685482 |
| | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus | Q39685724 |
| | Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition. | Q39713933 |
| | Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. | Q40041720 |
| | Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus | Q40125719 |
| | Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge | Q40546507 |
| | An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine | Q40940832 |
| | Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen | Q41683187 |
| | Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats | Q42209504 |
| | Novel polyvalent live vaccine against varicella-zoster and mumps virus infections | Q42279811 |
| | Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen | Q43613106 |
| | Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells | Q45394247 |
| | Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli | Q45589357 |
| | Rates of hospitalization for respiratory syncytial virus infection among children in medicaid | Q45739418 |
| | Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine | Q45823297 |
| | Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli | Q45856655 |
| | En passant mutagenesis: a two step markerless red recombination system. | Q50568023 |
| | Safety and immunogenicity of live attenuated varicella vaccine in 9-month-old children | Q73472877 |
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6085-6092 | |
| P577 | publication date | 2015-06-23 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity | |
| P478 | volume | 33 | |